Shareholders Approve Massive Increase in Authorized Common Stock, Enabling Future Dilution
UAMY has more than doubled off its 52-week low of $1.94.
Summary
UNITED STATES ANTIMONY CORP shareholders approved an amendment to increase authorized common stock, enabling future capital raises but also significant potential dilution.
Key Events · Financing and Capital Events · UAMY
-
Authorized Share Increase Approved
Shareholders approved an amendment to the Certificate of Formation to increase the number of shares authorized for issuance by the company. This follows a previous PRE 14A filing on April 10, 2026, which sought approval for a 'massive increase' in authorized common stock.
-
Directors Re-elected
All seven directors named in the Proxy Statement, including Gary C. Evans, Dr. Blaise Aguirre, and Lloyd Joseph Bardswich, were re-elected for a term of one year.
-
Auditor Ratified
The appointment of Sadler, Gibb & Associates, LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified by shareholders.
Analysis · UAMY · Manufacturing
Shareholders have approved an amendment to significantly increase the number of authorized shares. This approval, following a prior proxy statement flagging a 'massive increase,' provides the company with the ability to issue a substantial amount of new equity. Given the company's reported Q1 net loss of $11.3 million and high cash burn, this authorization is critical for future capital raises but also signals a high potential for significant dilution for existing shareholders.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 36.7% of the 1012 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.64%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UAMY was trading at $7.51 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $1.94 to $19.71. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.